Table 5.
Incubation Time |
||||||
---|---|---|---|---|---|---|
Extraction Buffer | Sample:Buffer Ratio | Additional Components | 5 min | 10 min | 15 min | 20 min |
Trizol LS | 1:3 | None | Below LOD | NT | NT | NT |
Viral RNA Buffer | 1:3 | 0.5% β-mercaptoethanol | Below LOD | NT | NT | NT |
Buffer AVL | 1:4 | Ethanol (44 % final) | Below LOD | NT | NT | NT |
UNEX | 1:1 | Ethanol (50 % final) | 0.7 ± 0.3 | Below LOD | NT | NT |
MagMAX Lysis/Binding Concentrate | 1:2 | None | 0.6 ± 0.06 | 0.5 ± 0.06 | NT | NT |
4 M Guanidine Thiocyanate+ 20 % Ethanol | 1:4 | Ethanol (20 % final) | 1 ± 0.3 | 0.9 ± 0.3 | 1.1 ± 0.1 | 0.8 ± 0.1 |
WPV1 isolate was incubated with extraction buffers Buffer AVL with ethanol, Trizol LS, UNEX, Viral RNA Buffer, MagMAX Lysis/Binding Concentrate, or 4 M guanidine thiocyanate with 20 % ethanol for the times indicated below. Samples were concentrated and resulting viral titers determined by CCID50 assay. LOD, Limit of detection (0.5 log10 CCID50/0.1 mL). NT, Not Tested.